BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shivapurkar N, Gazdar AF. DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med. 2010;10:123-132. [PMID: 20196733 DOI: 10.2174/156652410790963303] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Palanca-Ballester C, Rodriguez-Casanova A, Torres S, Calabuig-Fariñas S, Exposito F, Serrano D, Redin E, Valencia K, Jantus-Lewintre E, Diaz-Lagares A, Montuenga L, Sandoval J, Calvo A. Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers (Basel) 2021;13:3016. [PMID: 34208598 DOI: 10.3390/cancers13123016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Xiang S, Xiang T, Xiao Q, Li Y, Shao B, Luo T. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer. Int J Oncol 2017;51:801-11. [PMID: 28677721 DOI: 10.3892/ijo.2017.4064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
3 Zhao H, Ma C, Yan Y, Chen M. A sensitive cyclic signal amplification fluorescence strategy for determination of methyltransferase activity based on graphene oxide and RNase H. J Mater Chem B 2019;7:4520-7. [DOI: 10.1039/c9tb00743a] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Zhong X, Shen H, Mao J, Zhang J, Han W. Epigenetic silencing of protocadherin 10 in colorectal cancer. Oncol Lett. 2017;13:2449-2453. [PMID: 28454418 DOI: 10.3892/ol.2017.5733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Bi H, Liu Y, Pu R, Xia T, Sun H, Huang H, Zhang L, Zhang Y, Liu Y, Xu J, Rong J, Zhao Y. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk. Dig Dis Sci 2019;64:2158-66. [PMID: 30815821 DOI: 10.1007/s10620-019-05530-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Murphy SK. Targeting the epigenome in ovarian cancer. Future Oncol 2012;8:151-64. [PMID: 22335580 DOI: 10.2217/fon.11.152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
7 Deng QK, Lei YG, Lin YL, Ma JG, Li WP. Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients. Med Sci Monit 2016;22:516-21. [PMID: 26881880 DOI: 10.12659/msm.897179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
8 Draht MX, Riedl RR, Niessen H, Carvalho B, Meijer GA, Herman JG, van Engeland M, Melotte V, Smits KM. Promoter CpG island methylation markers in colorectal cancer: the road ahead. Epigenomics. 2012;4:179-194. [PMID: 22449189 DOI: 10.2217/epi.12.9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
9 Balgkouranidou I, Matthaios D, Karayiannakis A, Bolanaki H, Michailidis P, Xenidis N, Amarantidis K, Chelis L, Trypsianis G, Chatzaki E, Lianidou ES, Kakolyris S. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutat Res. 2015;778:46-51. [PMID: 26073472 DOI: 10.1016/j.mrfmmm.2015.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
10 Bethge N, Honne H, Hilden V, Trøen G, Eknæs M, Liestøl K, Holte H, Delabie J, Smeland EB, Lind GE. Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma. PLoS One 2013;8:e79602. [PMID: 24260260 DOI: 10.1371/journal.pone.0079602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
11 Khunger M, Kumar U, Roy HK, Tiwari AK. Dysplasia and cancer screening in 21st century. APMIS 2014;122:674-82. [DOI: 10.1111/apm.12283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Wang BH, Li YY, Han JZ, Zhou LY, Lv YQ, Zhang HL, Zhao L. Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood. Oncotarget 2017;8:31692-704. [PMID: 28404957 DOI: 10.18632/oncotarget.15919] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
13 Zhang Y, Zhang XR, Park JL, Kim JH, Zhang L, Ma JL, Liu WD, Deng DJ, You WC, Kim YS, Pan KF. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA. Oncotarget 2016;7:37132-44. [PMID: 27206798 DOI: 10.18632/oncotarget.9469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
14 Xiang T, Li L, Yin X, Yuan C, Tan C, Su X, Xiong L, Putti TC, Oberst M, Kelly K. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS One. 2012;7:e29783. [PMID: 22279545 DOI: 10.1371/journal.pone.0029783] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 8.8] [Reference Citation Analysis]
15 Li WH, Zhang H, Guo Q, Wu XD, Xu ZS, Dang CX, Xia P, Song YC. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. Dis Markers. 2015;2015:657570. [PMID: 25802477 DOI: 10.1155/2015/657570] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
16 Levenson VV, Melnikov AA. DNA methylation as clinically useful biomarkers-light at the end of the tunnel. Pharmaceuticals (Basel) 2012;5:94-113. [PMID: 24288045 DOI: 10.3390/ph5010094] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
17 Paczesny S, Duncan C, Jacobsohn D, Krance R, Leung K, Carpenter P, Bollard C, Renbarger J, Cooke K. Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example. Proteomics Clin Appl 2014;8:837-50. [PMID: 25196024 DOI: 10.1002/prca.201400033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Amiot A, Mansour H, Baumgaertner I, Delchier JC, Tournigand C, Furet JP, Carrau JP, Canoui-Poitrine F, Sobhani I. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening. PLoS One. 2014;9:e99233. [PMID: 25025467 DOI: 10.1371/journal.pone.0099233] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
19 Danese E, Minicozzi AM, Benati M, Montagnana M, Paviati E, Salvagno GL, Gusella M, Pasini F, Guidi GC, Lippi G. Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer. Br J Cancer. 2013;109:807-813. [PMID: 23839493 DOI: 10.1038/bjc.2013.351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
20 Bagheri H, Mosallaei M, Bagherpour B, Khosravi S, Salehi AR, Salehi R. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. J Gene Med 2020;22:e3189. [PMID: 32196834 DOI: 10.1002/jgm.3189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
21 Huang C, Zhou X, Li Z, Liu H, He Y, Ye G, Huang K. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma. Mol Med Rep 2016;14:2489-96. [PMID: 27485791 DOI: 10.3892/mmr.2016.5580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
22 DeLouize AM, Eick G, Karam SD, Snodgrass JJ. Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population-based research. Am J Hum Biol 2021;:e23665. [PMID: 34374148 DOI: 10.1002/ajhb.23665] [Reference Citation Analysis]
23 Fackler MJ, Lopez Bujanda Z, Umbricht C, Teo WW, Cho S, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Lyman JP, de Brot M, Ingle JN, Boughey J, McGuire K, King TA, Carey LA, Cope L, Wolff AC, Sukumar S. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res 2014;74:2160-70. [PMID: 24737128 DOI: 10.1158/0008-5472.CAN-13-3392] [Cited by in Crossref: 102] [Cited by in F6Publishing: 63] [Article Influence: 12.8] [Reference Citation Analysis]
24 Wu J, Zhang Y, Li M. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer. J Comput Biol 2019;26:1394-408. [PMID: 31290690 DOI: 10.1089/cmb.2019.0179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. Biomark Med 2013;7:49-58. [PMID: 23387484 DOI: 10.2217/bmm.12.111] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
26 Sapari NS, Loh M, Vaithilingam A, Soong R. Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One. 2012;7:e36275. [PMID: 22558417 DOI: 10.1371/journal.pone.0036275] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
27 Liu Y. The context of prostate cancer genomics in personalized medicine. Oncol Lett 2017;13:3347-53. [PMID: 28521441 DOI: 10.3892/ol.2017.5911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
28 Ibrahim J, Op de Beeck K, Fransen E, Peeters M, Van Camp G. The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types. Cancers (Basel) 2019;11:E1810. [PMID: 31752152 DOI: 10.3390/cancers11111810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Bethge N, Honne H, Andresen K, Hilden V, Trøen G, Liestøl K, Holte H, Delabie J, Lind GE, Smeland EB. A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma. PLoS One 2014;9:e104249. [PMID: 25226156 DOI: 10.1371/journal.pone.0104249] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 Albulescu A, Plesa A, Fudulu A, Iancu IV, Anton G, Botezatu A. Epigenetic approaches for cervical neoplasia screening (Review). Exp Ther Med 2021;22:1481. [PMID: 34765022 DOI: 10.3892/etm.2021.10916] [Reference Citation Analysis]
31 Manoochehri M, Borhani N, Karbasi A, Koochaki A, Kazemi B. Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesis. Oncol Lett 2016;12:285-90. [PMID: 27347139 DOI: 10.3892/ol.2016.4578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
32 Altobelli E, Angeletti PM, Latella G. Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis. J Cancer. 2016;7:1984-2004. [PMID: 27877214 DOI: 10.7150/jca.16244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
33 Kang I, Wang Y, Reagan C, Fu Y, Wang MX, Gu LQ. Designing DNA interstrand lock for locus-specific methylation detection in a nanopore. Sci Rep 2013;3:2381. [PMID: 24135881 DOI: 10.1038/srep02381] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
34 Ogawa T, Liggett TE, Melnikov AA, Monitto CL, Kusuke D, Shiga K, Kobayashi T, Horii A, Chatterjee A, Levenson VV, Koch WM, Sidransky D, Chang X. Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance. Cell Cycle 2012;11:1656-63. [PMID: 22487682 DOI: 10.4161/cc.20120] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
35 Lin Y, Sun G, Liu X, Li W, Ma J. Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma. J Int Med Res 2011;39:179-86. [DOI: 10.1177/147323001103900119] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
36 Margolin G, Petrykowska HM, Jameel N, Bell DW, Young AC, Elnitski L. Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development. J Mol Diagn 2016;18:283-98. [PMID: 26857064 DOI: 10.1016/j.jmoldx.2015.11.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
37 Hanash SM, Baik CS, Kallioniemi O. Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol. 2011;8:142-150. [PMID: 21364687 DOI: 10.1038/nrclinonc.2010.220] [Cited by in Crossref: 209] [Cited by in F6Publishing: 191] [Article Influence: 19.0] [Reference Citation Analysis]
38 Zhao ZH, Fan YC, Yang Y, Wang K. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2013; 19(41): 7189-7196 [PMID: 24222965 DOI: 10.3748/wjg.v19.i41.7189] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
39 Tolg C, Sabha N, Cortese R, Panchal T, Ahsan A, Soliman A, Aitken KJ, Petronis A, Bägli DJ. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab Invest 2011;91:825-36. [DOI: 10.1038/labinvest.2010.197] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
40 Qiu QA, Lv YF, Chen YM, Lin YG, Wu HY, Liu N. Transfection of methylated oligonucleotides inactivates the CHFR gene in human colon cancer cell line SW480. Shijie Huaren Xiaohua Zazhi 2010; 18(33): 3565-3568 [DOI: 10.11569/wcjd.v18.i33.3565] [Reference Citation Analysis]
41 Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer. Onco Targets Ther. 2017;10:4527-4534. [PMID: 28979144 DOI: 10.2147/ott.s142149] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
42 Rodríguez-paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17:330-9. [DOI: 10.1038/nm.2305] [Cited by in Crossref: 800] [Cited by in F6Publishing: 730] [Article Influence: 72.7] [Reference Citation Analysis]
43 Gobbini E, Swalduz A, Levra MG, Ortiz-Cuaran S, Toffart AC, Pérol M, Moro-Sibilot D, Saintigny P. Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer. Cancers (Basel) 2020;12:E3112. [PMID: 33114393 DOI: 10.3390/cancers12113112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Huang ZH, Hu Y, Hua D, Wu YY, Song MX, Cheng ZH. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Exp Mol Pathol. 2011;91:702-707. [PMID: 21884695 DOI: 10.1016/j.yexmp.2011.08.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
45 Rand KN, Young GP, Ho T, Molloy PL. Sensitive and selective amplification of methylated DNA sequences using helper-dependent chain reaction in combination with a methylation-dependent restriction enzymes. Nucleic Acids Res 2013;41:e15. [PMID: 22965136 DOI: 10.1093/nar/gks831] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
46 Han X, Wang J, Sun Y. Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics 2017;15:59-72. [PMID: 28392479 DOI: 10.1016/j.gpb.2016.12.004] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 22.6] [Reference Citation Analysis]
47 Epiphanio TMF, Fernandes NCCA, de Oliveira TF, Lopes PA, Réssio RA, Gonçalves S, Scattone NV, Tedardi MV, Kulikowski LD, Damasceno J, Loureiro APM, Dagli MLZ. Global DNA methylation of peripheral blood leukocytes from dogs bearing multicentric non-Hodgkin lymphomas and healthy dogs: A comparative study. PLoS One 2019;14:e0211898. [PMID: 30908498 DOI: 10.1371/journal.pone.0211898] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
48 Widschwendter M, Zikan M, Wahl B, Lempiäinen H, Paprotka T, Evans I, Jones A, Ghazali S, Reisel D, Eichner J, Rujan T, Yang Z, Teschendorff AE, Ryan A, Cibula D, Menon U, Wittenberger T. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer. Genome Med 2017;9:116. [PMID: 29268796 DOI: 10.1186/s13073-017-0500-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
49 Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR. DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions. Thyroid 2019;29:1244-54. [PMID: 31328658 DOI: 10.1089/thy.2018.0458] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Wu TH, Hsiue EH, Yang JC. Opportunities of circulating tumor DNA in lung cancer. Cancer Treat Rev 2019;78:31-41. [PMID: 31326635 DOI: 10.1016/j.ctrv.2019.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
51 Maccani MA, Knopik VS. Cigarette smoke exposure-associated alterations to non-coding RNA. Front Genet 2012;3:53. [PMID: 22509180 DOI: 10.3389/fgene.2012.00053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
52 Nehme E, Rahal Z, Sinjab A, Khalil A, Chami H, Nemer G, Kadara H. Epigenetic Suppression of the T-box Subfamily 2 (TBX2) in Human Non-Small Cell Lung Cancer. Int J Mol Sci 2019;20:E1159. [PMID: 30866410 DOI: 10.3390/ijms20051159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
53 Huang X, Wu C, Fu Y, Guo L, Kong X, Cai H. Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China. Bull Cancer 2018;105:746-54. [PMID: 30126609 DOI: 10.1016/j.bulcan.2018.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
54 Rubio-Ramos A, Labat-de-Hoz L, Correas I, Alonso MA. The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer. Cells 2021;10:1065. [PMID: 33946345 DOI: 10.3390/cells10051065] [Reference Citation Analysis]
55 Mukherjee S, Dasgupta S, Mishra PK, Chaudhury K. Air pollution-induced epigenetic changes: disease development and a possible link with hypersensitivity pneumonitis. Environ Sci Pollut Res Int 2021;28:55981-6002. [PMID: 34498177 DOI: 10.1007/s11356-021-16056-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kirby MK, Ramaker RC, Roberts BS, Lasseigne BN, Gunther DS, Burwell TC, Davis NS, Gulzar ZG, Absher DM, Cooper SJ, Brooks JD, Myers RM. Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns. BMC Cancer 2017;17:273. [PMID: 28412973 DOI: 10.1186/s12885-017-3252-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
57 Liu S. Epigenetics advancing personalized nanomedicine in cancer therapy. Adv Drug Deliv Rev 2012;64:1532-43. [PMID: 22921595 DOI: 10.1016/j.addr.2012.08.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
58 Iacobazzi V, Castegna A, Infantino V, Andria G. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 2013;110:25-34. [PMID: 23920043 DOI: 10.1016/j.ymgme.2013.07.012] [Cited by in Crossref: 145] [Cited by in F6Publishing: 137] [Article Influence: 16.1] [Reference Citation Analysis]
59 Shin CM, Kim N, Jung Y, Park JH, Kang GH, Park WY, Kim JS, Jung HC, Song IS. Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer. Helicobacter 2011;16:179-88. [PMID: 21585603 DOI: 10.1111/j.1523-5378.2011.00838.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
60 Zang R, Wang X, Jin R, Lei Y, Huang J, Liu C, Zheng S, Zhou F, Wu Q, Sun N, Gao S, He J. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity. J Transl Med 2019;17:430. [PMID: 31888670 DOI: 10.1186/s12967-019-2117-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Otoukesh B, Boddouhi B, Moghtadaei M, Kaghazian P, Kaghazian M. Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int 2018;18:158. [PMID: 30349420 DOI: 10.1186/s12935-018-0654-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 9.5] [Reference Citation Analysis]
62 Jankowska AM, Millward CL, Caldwell CW. The potential of DNA modifications as biomarkers and therapeutic targets in oncology. Expert Rev Mol Diagn 2015;15:1325-37. [PMID: 26394702 DOI: 10.1586/14737159.2015.1084229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
63 Chen F, Huang T, Ren Y, Wei J, Lou Z, Wang X, Fan X, Chen Y, Weng G, Yao X. Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis. BMC Urol 2016;16:52. [PMID: 27578166 DOI: 10.1186/s12894-016-0171-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
64 Santarpia M, Liguori A, D'Aveni A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, Lazzari C, Altavilla G, Rosell R. Liquid biopsy for lung cancer early detection. J Thorac Dis 2018;10:S882-97. [PMID: 29780635 DOI: 10.21037/jtd.2018.03.81] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
65 Kamiyama H, Noda H, Konishi F, Rikiyama T. Molecular biomarkers for the detection of metastatic colorectal cancer cells. World J Gastroenterol 2014; 20(27): 8928-8938 [PMID: 25083065 DOI: 10.3748/wjg.v20.i27.8928] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
66 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
67 Weiss G, Schlegel A, Kottwitz D, König T, Tetzner R. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease. J Thorac Oncol 2017;12:77-84. [PMID: 27544059 DOI: 10.1016/j.jtho.2016.08.123] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
68 Trifa F, Karray-chouayekh S, Jmaa ZB, Jmal E, Khabir A, Sellami-boudawara T, Frikha M, Daoud J, Mokdad-gargouri R. Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance. Med Oncol 2013;30. [DOI: 10.1007/s12032-012-0418-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
69 Matthaios D, Balgkouranidou I, Karayiannakis A, Bolanaki H, Xenidis N, Amarantidis K, Chelis L, Romanidis K, Chatzaki A, Lianidou E, Trypsianis G, Kakolyris S. Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer. Oncol Lett 2016;12:748-56. [PMID: 27347211 DOI: 10.3892/ol.2016.4649] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
70 Cortese R, Kwan A, Lalonde E, Bryzgunova O, Bondar A, Wu Y, Gordevicius J, Park M, Oh G, Kaminsky Z, Tverkuviene J, Laurinavicius A, Jankevicius F, Sendorek DH, Haider S, Wang SC, Jarmalaite S, Laktionov P, Boutros PC, Petronis A. Epigenetic markers of prostate cancer in plasma circulating DNA. Hum Mol Genet 2012;21:3619-31. [PMID: 22619380 DOI: 10.1093/hmg/dds192] [Cited by in F6Publishing: 34] [Reference Citation Analysis]
71 Mcnally B, Linder M, Valdes R. Epigenetic primer for diagnostic applications: a window into personalized medicine. Personalized Medicine 2014;11:323-37. [DOI: 10.2217/pme.14.21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Lin Y, Li Z, He Z, Guan T, Ma J. Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer. J Int Med Res 2012;40:2117-23. [DOI: 10.1177/030006051204000609] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
73 Wang J, Han X, Sun Y. DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer. Sci China Life Sci 2017;60:356-62. [DOI: 10.1007/s11427-016-0253-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
74 Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e1S-29S. [PMID: 23649439 DOI: 10.1378/chest.12-2345] [Cited by in Crossref: 313] [Cited by in F6Publishing: 313] [Article Influence: 34.8] [Reference Citation Analysis]
75 Li L, Choi JY, Lee KM, Sung H, Park SK, Oze I, Pan KF, You WC, Chen YX, Fang JY. DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology. J Epidemiol. 2012;22:384-394. [PMID: 22863985 DOI: 10.2188/jea.je20120003] [Cited by in Crossref: 89] [Cited by in F6Publishing: 56] [Article Influence: 8.9] [Reference Citation Analysis]
76 Guarrera S, Viberti C, Cugliari G, Allione A, Casalone E, Betti M, Ferrante D, Aspesi A, Casadio C, Grosso F, Libener R, Piccolini E, Mirabelli D, Dianzani I, Magnani C, Matullo G. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects. J Thorac Oncol 2019;14:527-39. [PMID: 30408567 DOI: 10.1016/j.jtho.2018.10.163] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
77 Hu W, Zheng W, Liu Q, Chu H, Chen S, Kim JJ, Wu J, Si J. Diagnostic accuracy of DNA methylation in detection of gastric cancer: a meta-analysis. Oncotarget 2017;8:113142-52. [PMID: 29348893 DOI: 10.18632/oncotarget.22613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]